Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance

Allergologia et Immunopathologia

Volumn 35, Issue 4, 2007, Pages 126-129

  Andri, L ^a   Falagiani, Paolo ^b  

^a MAGGIORE HOSPITAL   (Italy)

^b Lofarma SpA   (Italy)

Author keywords

ASA NSAIDs; Celecoxib; Cutaneous reactions; Intolerance; Safety

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; AGED; ALLERGIC REACTION; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PROVOCATION TEST; SKIN MANIFESTATION; URTICARIA;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 2 INHIBITORS; DRUG ERUPTIONS; ERYTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRAZOLES; SINGLE-BLIND METHOD; SULFONAMIDES;

EID: 34548775825     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1157/13108222     Document Type: Article

References (48)

1. ACR. Clinical Guidelines Committee. Guidelines for management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
2. Henry DA. Side-effects of non steroidal antinflammatory drugs. Balliers Clin Rheumatol 1989;2:425-54.
3. Shorrock CJ, Langman MJS. Non steroidal anti-inflammatory drugs induced gastro-duodenal damage. Epidemiology Dig Dis 1995;12(suppl 1):3-8.
4. Settipane GA. Aspirin and allergic diseases. Am J Med. 1983;74:102-10.
5. Pleskow WN, Stevenson DD, Mathison DA. Aspirin sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983;71:574-9.
6. Mathison DA, Lumry WR, Stevenson DD. Aspirin in chronic urticaria and/or angioedema: studies of sensitivity and desensitization. J Allergy Clin Immunol 1982;69:135 (abstr.).
7. Asero R. Multiple sensitivity to NSAIDs. Allergy 2000;55:893-4.
8. An S, Goetzel EJ. Lipid mediators of hypersensitivity and inflammation. In: Middleton E, Reed CE, Ellis EF, Adkinson F Jr, Yunginger JW, Busse WW eds: Allergy. Principles and Practice (Fifth edition). Baltimore, Mosby St. Louis, 1998; p. 168-82.
9. Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudo-allergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-80.
10. Ispano M, Fontana A, Scibilia J, Ortolani C. Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs 1993;46(suppl 1):253-6.
11. Ortolani C, D'Amato G, Giannetti A, Marone G, Moscato G, Meneghini A. Memorandum SIAIC della diagnosi di allergia/intolleranza ai farmaci. Ital J Allergy Clin Immunol 1998;8:568-95.
12. Schlumberger HD. Drug-induced pseudo-allergic syndrome as exemplified by acetylsalicylic intolerance. In: Dukor P, Kallos P, Schlumberger HD, West GB eds: Pseudoallergic reactions. Involvement of drugs and chemicals. Basel, Karger, 1980, p. 125-203.
13. Szczeklik A. The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990;3:588-93.
14. Stevenson DD, Lewis RA. Proposed mechanism of aspirin sensitivity reactions. J Allergy Clin Immunol 1987;80:788-90.
15. Lee TH. Mechanism of aspirin sensitivity. Am Rev Resp Dis 1992;145:34-6.
16. Szczeklik A, Stevenson DD. Aspirin induced asthma: advance in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
17. Szczeklik A, Stevenson DD. Aspirin induced asthma: advance in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2003;111:913-21.
18. Bolten WW. Scientific rationale for specific inhibition of COX-2. J Rheumatology 1998;25:2-7.
19. Wallace JL. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of non steroidal anti-inflammatory drugs (NSAIDs). Am J Med 1999;107:S11-7.
20. Sousa A, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-Schumann M, et al. Enhanced expression of cyclo-oxygenase isoenzyme-2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997;52:940-5.
21. Dahlen B, Szczeklik A, Murray JJ. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. N Engl J Med 2001;344:142.
22. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Perez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann Allergy Asthma Immunol 2001;87:201-4.
23. Woessner KM, Simon RA, Stevenson DD. The safety of Celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002;46:2201-6.
24. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Invest Allergol Clin Immunol 2003;13:20-5.
25. Garcia-Rodriguez RM, Hinojosa M, Camacho-Garrido E, Borges-Gimeno P, Martin-Garcia C. Celecoxib, safe in NSAID intolerance. Allergy 2002;57:1085-6.
26. Senna GE, Bilò MB, Antonicelli L. Tolerability of three selective ciclo-oxygenase-2 inhibitors, meloxicam, Celecoxib and rofecoxib in NSAID-sensitive patients. Eur Ann Allergy Clin Immunol 2004;36:215-8.
27. Liccardi G, Salzillo A, Piccolo A, Senna GE, Piscitelli E, D'Amato M. Safety of Celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs. Eur Ann Allergy Clin Immunol 2005;37:50-3.
28. Liccardi G, D'Amato G, Canonica GW, Lobefalo G, Noschese P, Piccolo A, et al. Safety of Celecoxib in patients with adverse reactions to nimesulide. Allergy 2005;60:708-9.
29. Viola M, Quarantino D, Gaeta F, Caringi M, Valluzzi R, Caruso C, Volpetti S, Romano A. Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;137:145-50.
30. Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-80.
31. Hubky R, Vermeulen C, Bachmeyer C, Charouol A, Mofredi A. Anaphylactic shock induced by Celecoxib. Ann Int Med 2001;152:355.
32. Levy MB, Fink JN. Anaphylaxis to Celecoxib. Ann Allergy Asthma Immunol 2001;87:72-3.
33. Grob M, Pichler WJ, Wüthrich B. Anaphylaxis to Celecoxib. Allergy 2002;57:264-5.
34. Gagnon R, Julien M, Gold P. Selective Celecoxib-associated anaphylactoid reaction. J Allergy Clin Immunol 2003;111:1404-5.
35. Marques S, Milpied B, Foulc B, Barbarot S. Toxidermies graves aux Celecoxib (Celebrex). Ann Dermatol Venereol 2003;130:1051-5.
36. Grob M, Scheidegger P, Wütrich B. Allergic skin reaction to Celecoxib. Dermatology 2000;201:383.
37. Fye KH, Crowley E, Berger TG, Le Boit P, Conolly MK. Celecoxib-induced Sweet's syndrome. J Am Acad Dermatol 2001;45:300-2.
38. Adverse Drug Reactions Advisory Committee (ADRAC). Australian adverse drug reactions bulletin. Celecoxib: early Australian reporting experience 2000;19:6.
39. Mommens V, Just N, Ngo MT, Cott L, Fournier C, Wallaert B. Intolérance aux anti-inflammatoires non stéroïdiens inhibiteurs spécifiques de la cyclo-oxygénase 2. Rev Fr Allergol 2003;43:393-6.
40. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs. Clin Rev Allergy Immunol 2003;24:125-36.
41. Mc Morran M, Morawieka C. Celecoxib (Celebrex): 1 year late. C M A J 2000;162:1048-50.
42. Knowles S, Shapiro L, Shear NH. Should Celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of "sulfa" allergy. Drug Saf 2001;24:239-47.
43. Schuster C, Wüthrich B. Anaphylactic drug reaction to Celecoxib and sulphametoxazole: cross reactivity or coincidence? Allergy 2003;58:1072.
44. Andri L, Senna GE, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, et al. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy 1994;72:29-32.
45. Senna GE, Andri G, Dama AR, Mezzelani P, Andri L. Tolerability of imidazole salicilate in aspirin-sensitive patients. Allergy Proc 1995;16:251-4.
46. Fradet G, Robin-Le Nechet A, Huguenin H, Chiffoleau A. Sindrome d'hypersensibilitè au Celecoxib. Ann Med Intern 2003;154:181-2.
47. Deeks JJ, Smith LA, Global P, Bradley MD. Efficacy, tolerability and upper gastrointestinal safety of Celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ 2002;325:619-23.
48. Moskowitz RW, Sunshine A, Brugger A, Lefkowith JB, Zhao WW, Geis GS. American pain society pain questionnaire and other pain measures in the assessment of osteoarthritis pain: a pooled analysis of three celecoxib pivotal studies. Am J Ther 2003;10:12-20.